One procedure—one report: the Re-Imagine Cytopathology Task Force position paper on small tissue biopsy triage in anatomic pathology.

Endoscopic biopsy procedures increasingly generate multiple tissue samples from multiple sites, and frequently retrieve concurrent cytologic specimens and small core needle biopsies. There is currently lack of consensus in subspecialized practices as to whether cytopathologists or surgical pathologists should review such samples, and whether the pathology findings should be reported together or separately. In December 2021, the American Society of Cytopathology convened the Re-Imagine Cytopathology Task Force to examine various workflows that would facilitate unified pathology reporting of concurrently obtained biopsies and improve clinical care. This position paper summarizes the key points and highlights the advantages, challenges, and resources available to support the implementation of such workflows that result in "one procedure-one report". • Issuing 1 unified pathology report for all concurrently obtained biopsies derived from 1 procedure would be advantageous. • A cytopathology-driven workflow with serial review of specimens by cytopathologists first, followed by surgical pathologists, would be a relatively integrative approach to enable unified pathology reporting in subspecialized practices. • Cytotechnologist/cytologist skill sets and training are evolving into a highly valuable resource and they are now able to support and/or lead multiple laboratory functions. • Establishing workflow expectations upfront is important for successful implementation of workflow modifications. [ABSTRACT FROM AUTHOR]